CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma

Summary

Phase II trial to study the effectiveness of CCI-779 in treating patients who have mantle cell non-Hodgkin's lymphoma. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.

Timeline

Start

2002-04

Primary completion

2006-02

Completion

2008-02

Drugs

Indications